These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 15960552)

  • 61. Pimecrolimus cream and Tacrolimus ointment in the treatment of atopic dermatitis: a pilot study on patient preference.
    Onumah N; Kircik L
    J Drugs Dermatol; 2013 Oct; 12(10):1145-8. PubMed ID: 24085050
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Bilateral comparison study of pimecrolimus cream 1% and a ceramide-hyaluronic acid emollient foam in the treatment of patients with atopic dermatitis.
    Frankel A; Sohn A; Patel RV; Lebwohl M
    J Drugs Dermatol; 2011 Jun; 10(6):666-72. PubMed ID: 21637908
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Emerging Treatment Options in Atopic Dermatitis: Topical Therapies.
    Nygaard U; Deleuran M; Vestergaard C
    Dermatology; 2017; 233(5):333-343. PubMed ID: 29216643
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Atopic Dermatitis: Diagnosis and Treatment.
    Frazier W; Bhardwaj N
    Am Fam Physician; 2020 May; 101(10):590-598. PubMed ID: 32412211
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Use of pimecrolimus cream in disorders other than atopic dermatitis.
    Day I; Lin AN
    J Cutan Med Surg; 2008; 12(1):17-26. PubMed ID: 18258153
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Low systemic absorption and good tolerability of pimecrolimus, administered as 1% cream (Elidel) in infants with atopic dermatitis--a multicenter, 3-week, open-label study.
    Staab D; Pariser D; Gottlieb AB; Kaufmann R; Eichenfield LF; Langley RG; Scott G; Ebelin ME; Barilla D; Schmidli H; Burtin P
    Pediatr Dermatol; 2005; 22(5):465-71. PubMed ID: 16191004
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Atopic dermatitis management with tacrolimus ointment (Protopic).
    Kapp A; Allen BR; Reitamo S
    J Dermatolog Treat; 2003; 14(Suppl 1):5-16. PubMed ID: 14522634
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Tacrolimus ointment: a review of its use in atopic dermatitis and its clinical potential in other inflammatory skin conditions.
    Simpson D; Noble S
    Drugs; 2005; 65(6):827-58. PubMed ID: 15819596
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Practical algorithm to inform clinical decision-making in the topical treatment of atopic dermatitis.
    Luger T; Adaskevich U; Anfilova M; Dou X; Murashkin NN; Namazova-Baranova L; Nitochko O; Reda A; Svyatenko TV; Tamay Z; Tawara M; Vishneva EA; Vozianova S; Wang H; Zhao Z
    J Dermatol; 2021 Aug; 48(8):1139-1148. PubMed ID: 33963603
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Safety of topical calcineurin inhibitors for the treatment of atopic dermatitis.
    Munzenberger PJ; Montejo JM
    Pharmacotherapy; 2007 Jul; 27(7):1020-8. PubMed ID: 17594208
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Topical tacrolimus and pimecrolimus: future directions.
    Ling MR
    Semin Cutan Med Surg; 2001 Dec; 20(4):268-74. PubMed ID: 11770914
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pharmacoeconomics of drug therapy for atopic dermatitis.
    Lamb SR; Rademaker M
    Expert Opin Pharmacother; 2002 Mar; 3(3):249-55. PubMed ID: 11866675
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Tacrolimus ointment: a new therapy for atopic dermatitis--review of the literature.
    Pustisek N; Lipozencić J; Ljubojević S
    Acta Dermatovenerol Croat; 2002 Mar; 10(1):25-32. PubMed ID: 12137728
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Clinical management of atopic eczema with pimecrolimus cream 1% (Elidel) in paediatric patients.
    Eichenfield LF; Thaci D; de Prost Y; Puig L; Paul C
    Dermatology; 2007; 215 Suppl 1():3-17. PubMed ID: 18174689
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A single-center open-label long-term comparison of tacrolimus ointment and topical corticosteroids for treatment of atopic dermatitis.
    Neumann E; Amtage D; Bruckner-Tuderman L; Mockenhaupt M
    J Dtsch Dermatol Ges; 2008 Jul; 6(7):548-53. PubMed ID: 18248495
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Economic Evaluation of Dupilumab for Moderate-to-Severe Atopic Dermatitis: A Cost-Utility Analysis.
    Zimmermann M; Rind D; Chapman R; Kumar V; Kahn S; Carlson J
    J Drugs Dermatol; 2018 Jul; 17(7):750-756. PubMed ID: 30005097
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pimecrolimus 1% cream for the treatment of atopic dermatitis.
    Wolff K
    Skin Therapy Lett; 2005 Oct; 10(8):1-6. PubMed ID: 16292456
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Pimecrolimus cream 1%: a new development in nonsteroid topical treatment of inflammatory skin diseases.
    Hebert AA; Warken KA; Cherill R
    Semin Cutan Med Surg; 2001 Dec; 20(4):260-7. PubMed ID: 11770913
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pimecrolimus in dermatology: atopic dermatitis and beyond.
    Gisondi P; Ellis CN; Girolomoni G
    Int J Clin Pract; 2005 Aug; 59(8):969-74. PubMed ID: 16033622
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Adult patients with moderate atopic dermatitis: tacrolimus ointment versus pimecrolimus cream.
    Abramovits W; Fleischer AB; Jaracz E; Breneman D
    J Drugs Dermatol; 2008 Dec; 7(12):1153-8. PubMed ID: 19137769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.